Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.21 is 143% above its 5-year average of -0.48, around the middle of its 5-year range (-1.14–1.11).
135.29% above its 12-month average of -0.59.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:20:49.608Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.21
EARNINGS PER SHARE (EPS) AVG TTM
-0.59
EARNINGS PER SHARE (EPS) AVG 3Y
-0.72
EARNINGS PER SHARE (EPS) AVG 5Y
-0.48
EARNINGS PER SHARE (EPS) AVG 10Y
-0.66
EARNINGS PER SHARE (EPS) AVG 15Y
-0.71
EARNINGS PER SHARE (EPS) AVG 20Y
-0.76
CURRENT VS TTM AVG
+135.29%
CURRENT VS 3Y AVG
+129.27%
CURRENT VS 5Y AVG
+143.45%
CURRENT VS 10Y AVG
+131.60%
CURRENT VS 15Y AVG
+129.55%
CURRENT VS 20Y AVG
+127.56%
AtriCure, Inc.
Market Cap
$2.87B
Earnings Per Share (EPS)
0.21
TTM Avg
-0.59
3Y Avg
-0.72
5Y Avg
-0.48
Market Cap
$2.87B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$2.88B
Earnings Per Share (EPS)
-3.33
TTM Avg
-3.42
3Y Avg
-3.51
5Y Avg
-3.03
Market Cap
$2.69B
Earnings Per Share (EPS)
1.26
TTM Avg
1.10
3Y Avg
0.11
5Y Avg
-0.77
Market Cap
$2.69B
Earnings Per Share (EPS)
-12.45
TTM Avg
-4.69
3Y Avg
-1.64
5Y Avg
-2.01
Market Cap
$3.09B
Earnings Per Share (EPS)
-1.41
TTM Avg
-2.98
3Y Avg
-2.05
5Y Avg
-1.75
Market Cap
$2.64B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.45
3Y Avg
-0.45
5Y Avg
-0.45
Market Cap
$2.64B
Earnings Per Share (EPS)
-0.86
TTM Avg
-2.70
3Y Avg
-2.81
5Y Avg
-3.40
Market Cap
$3.15B
Earnings Per Share (EPS)
0.21
TTM Avg
-0.65
3Y Avg
-2.68
5Y Avg
-3.12
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | $2.87B | 0.21 | -0.59 | -0.72 | -0.48 |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 3.86 | 3.33 | 1.17 | 0.32 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | -3.33 | -3.42 | -3.51 | -3.03 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 1.26 | 1.10 | 0.11 | -0.77 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | -12.45 | -4.69 | -1.64 | -2.01 |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | -1.41 | -2.98 | -2.05 | -1.75 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | N/A | -0.45 | -0.45 | -0.45 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -0.86 | -2.70 | -2.81 | -3.40 |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 0.21 | -0.65 | -2.68 | -3.12 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | -2.84 | -2.77 | -2.30 | -1.82 |
Trailing EPS (TTM)
$0.21
Forward EPS (Est.)
$0.11
P/E Ratio
265.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.24 |
| 2024-12-31 | -0.95 |
| 2023-12-31 | -0.66 |
| 2022-12-31 | -1.02 |
| 2021-12-31 | 1.11 |
| 2020-12-31 | -1.14 |
| 2019-12-31 | -0.94 |
| 2018-12-31 | -0.62 |
| 2017-12-31 | -0.83 |
| 2016-12-31 | -1.05 |
| 2015-12-31 | -0.97 |
| 2014-12-31 | -0.61 |
| 2013-12-31 | -0.56 |
| 2012-12-31 | -0.47 |
| 2011-12-31 | -0.35 |
| 2010-12-31 | -0.25 |
| 2009-12-31 | -1.13 |
| 2008-12-31 | -0.72 |
| 2007-12-31 | -0.84 |
| 2006-12-31 | -1.13 |
| 2005-12-31 | -2.10 |
| 2004-12-31 | -5.17 |
| 2003-12-31 | -3.97 |
| 2002-12-31 | -5.08 |
| 2001-12-31 | -2.04 |
